Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
69th of 261 in
Neurosciences
-
40th of 261 in
Pharmacology & Pharmacy
Contents
Current Neuropharmacology, Volume 17 - Number 1
Biography Open Access
Preface Open Access
Editorial Open Access
The Era of Cerebellar Therapy
, 17(1): 3 - 6Hiroshi Mitoma* and Mario Manto
DOI: 10.2174/1570159X1701181129111212
Review Article
Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
, 17(1): 7 - 13Roger Kalla and Michael Strupp*
DOI: 10.2174/1570159X16666180905093535
Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
Review Article
Noninvasive Cerebellar Stimulation as a Complement Tool to Pharmacotherapy
, 17(1): 14 - 20Roberta Ferrucci*, Tommaso Bocci, Francesca Cortese, Fabiana Ruggiero and Alberto Priori
DOI: 10.2174/1570159X15666171114142422
Noninvasive Cerebellar Stimulation as a Complement Tool to Pharmacotherapy
Review Article
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
, 17(1): 21 - 32Emanuele Barca*, Valentina Emmanuele, Salvatore DiMauro, Antonio Toscano and Catarina M. Quinzii
DOI: 10.2174/1570159X15666171109125643
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias
Review Article
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
, 17(1): 33 - 58Hiroshi Mitoma*, Mario Manto and Christiane S. Hampe
DOI: 10.2174/1570159X16666180917105033
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
General Review Article
Statins and the Brain: More than Lipid Lowering Agents?
, 17(1): 59 - 83Anna Fracassi , Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni and Marco Segatto*
DOI: 10.2174/1570159X15666170703101816
Statins and the Brain: More than Lipid Lowering Agents?
General Review Article
Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications
, 17(1): 84 - 98Ivana Grković*, Dunja Drakulić, Jelena Martinović and Nataša Mitrović
DOI: 10.2174/1570159X15666170518151541
Role of Ectonucleotidases in Synapse Formation During Brain Development: Physiological and Pathological Implications
General Review Article Open Access
Relevance of CYP2C9 Function in Valproate Therapy
, 17(1): 99 - 106Katalin Monostory*, Andrea Nagy, Katalin Tóth, Tamás Bűdi , Ádám Kiss, Máté Déri and Gábor Csukly
DOI: 10.2174/1570159X15666171109143654
Relevance of CYP2C9 Function in Valproate Therapy
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
View Full Editorial Board
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
Biography of T.E. Salt
Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.
Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Scopus CiteScore Metrics: 1.38
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net